Ooi Poh Ling, Zainal Hadzliana, Lean Qi Ying, Ming Long Chiau, Ibrahim Baharudin
Department of Pharmacy, Hospital Sultan Abdul Halim, Sungai Petani 08000, Kedah, Malaysia.
School of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town 11800, Penang, Malaysia.
Pharmacy (Basel). 2021 Oct 1;9(4):161. doi: 10.3390/pharmacy9040161.
The emergence of new technologies in the area of health information and communication helps pharmacists to check the safety of medications used via electronic prescribing. The study aimed to identify the rate and types of problems with electronic prescriptions (e-prescriptions) that required pharmacist intervention at an inpatient pharmacy, and to evaluate prescribers' acceptance of these interventions. A retrospective cross-sectional study on the interventions of e-prescriptions documented by pharmacists was conducted in a public hospital inpatient pharmacy. Data were collected for descriptive analysis using a collection form, including the e-prescription interventions, types of wards, drugs involved, and acceptance of intervention by prescribers. A chi-square test was used to evaluate the association between ward pharmacist availability and the rate of interventions. A total number of 11,922 (3.3%) pharmacist interventions were proposed for 357,760 e-prescriptions ordered in the 12 month study period. Of the total number of proposed interventions, 11,381 (95.5%) were accepted by prescribers. The interventions on e-prescriptions were from surgical wards (11.7%) followed by intensive care (5.6%), paediatric (3.5%) and medical specialty wards (2.9%). Anti-infective agents (33.8%) and cardiovascular medicines (27.0%) were among the drugs with the highest rate of interventions. The most common type of intervention was revising the drug regimen (58.4%), especially with anti-infective agents (33.8%). Prescribers in surgical wards showed the highest level of acceptance of pharmacist interventions, which was 97.37%. The presence of ward pharmacists showed a higher number of interventions (6.2 vs. 1.0%, < 0.001) than wards without pharmacists, as well as a higher percentage of acceptance (96.4 vs. 91.1%, < 0.001) towards e-prescription intervention. In e-prescribing, errors can be prevented by pharmacists' interventions on e-prescriptions. This helps to prevent medication errors and thus optimise rational pharmacotherapy in patients. The role of ward pharmacists in pharmaceutical care is highly accepted by prescribers.
健康信息与通信领域新技术的出现有助于药剂师通过电子处方检查所用药物的安全性。该研究旨在确定住院药房中需要药剂师干预的电子处方（e处方）问题的发生率和类型，并评估开处方者对这些干预措施的接受程度。在一家公立医院的住院药房对药剂师记录的电子处方干预措施进行了一项回顾性横断面研究。使用收集表收集数据进行描述性分析，包括电子处方干预措施、病房类型、涉及的药物以及开处方者对干预措施的接受情况。采用卡方检验评估病房药剂师的配备情况与干预率之间的关联。在为期12个月的研究期内，针对357,760份电子处方共提出了11,922次（3.3%）药剂师干预措施。在提出的干预措施总数中，11,381次（95.5%）被开处方者接受。电子处方干预措施来自外科病房（11.7%），其次是重症监护病房（5.6%）、儿科病房（3.5%）和内科专科病房（2.9%）。干预率最高的药物包括抗感染药物（33.8%）和心血管药物（27.0%）。最常见的干预类型是修改药物治疗方案（58.4%），尤其是抗感染药物（33.8%）。外科病房的开处方者对药剂师干预措施的接受程度最高，为97.37%。有病房药剂师的病房比没有药剂师的病房有更多的干预措施（6.2%对1.0%，<0.001），对电子处方干预措施的接受百分比也更高（96.4%对91.1%）。在电子处方中，药剂师对电子处方的干预可以预防错误。这有助于预防用药错误，从而优化患者的合理药物治疗。病房药剂师在药学服务中的作用得到了开处方者的高度认可。
